ReNuNerve

Diabetes is a pervasive yet often underestimated health condition, affecting 38 million individuals in the United States alone, constituting 11% of the population, with an additional 115 million at risk due to prediabetes. Among different complications of diabetes, one particularly alarming comorbidity is diabetic neuropathy, characterized by the gradual loss of sensation in the feet. This numbness not only compromises patients’ ability to perceive pain but also alters their gait, setting the stage for the development of foot ulcers. A callus can rapidly progress to a severe ulcer, jeopardizing the affected individual’s mobility and quality of life. Diabetic foot care also costs the US healthcare system 13 billion dollars every year. Tragically, up to half of diabetic patients with foot ulcers will ultimately face lower limb amputation, underscoring the urgent need for prevention of diabetic foot ulcers.

ReNuNerve is an innovative wearable gait retraining device to prevent ulcer formation. Tens of literature has shown that high peak plantar pressure is one of the leading causes of callus and ulcer formation, our device can timely alert patients of high plantar area on their feet through sensory feedback on their knee. Our device can achieve a preliminary 40% of pressure reduction under patients’ feet as proven by our study.